Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. Drug (Description in trials) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY Disease ID
1Denosumab
(Synonym: Prolia (TN))		[1] Denosumab (Synonym: Prolia)[1] D03684 (Name: Prolia (TN))[1] TNFSF11 💬[8] Breast cancer, Chemical carcinogenesis - receptor activation, Cytokine-cytokine receptor interaction, NF-kappa B signaling pathway, Osteoclast differentiation, Parathyroid hormone synthesis, secretion and action, Prolactin signaling pathway, Rheumatoid arthritis 💬[7] 46, 50, 93, 95, 96, 274, 299
2Denosumab - - Immunoglobulin G2 Human Monoclonal Antibody to RANK Ligand
(Synonym: Prolia (TN))		[1] Denosumab (Synonym: Prolia)[1] D03684 (Name: Prolia (TN))[1] TNFSF11 💬[8] Breast cancer, Chemical carcinogenesis - receptor activation, Cytokine-cytokine receptor interaction, NF-kappa B signaling pathway, Osteoclast differentiation, Parathyroid hormone synthesis, secretion and action, Prolactin signaling pathway, Rheumatoid arthritis 💬[1] 274
3Denosumab - Immunoglobulin G2 Human Monoclonal Antibody to RANK Ligand
(Synonym: Prolia (TN))		[1] Denosumab (Synonym: Prolia)[1] D03684 (Name: Prolia (TN))[1] TNFSF11 💬[8] Breast cancer, Chemical carcinogenesis - receptor activation, Cytokine-cytokine receptor interaction, NF-kappa B signaling pathway, Osteoclast differentiation, Parathyroid hormone synthesis, secretion and action, Prolactin signaling pathway, Rheumatoid arthritis 💬[1] 274
4PRALIA 60 mg Subcutaneous Injection Syringe(denosumab)
(Synonym: Prolia (TN))		[1] Denosumab (Synonym: Prolia)[1] D03684 (Name: Prolia (TN))[1] TNFSF11 💬[8] Breast cancer, Chemical carcinogenesis - receptor activation, Cytokine-cytokine receptor interaction, NF-kappa B signaling pathway, Osteoclast differentiation, Parathyroid hormone synthesis, secretion and action, Prolactin signaling pathway, Rheumatoid arthritis 💬[1] 46
5PRALIA 60mg Subcutaneous Injection Syringe(denosumab)
(Synonym: Prolia (TN))		[1] Denosumab (Synonym: Prolia)[1] D03684 (Name: Prolia (TN))[1] TNFSF11 💬[8] Breast cancer, Chemical carcinogenesis - receptor activation, Cytokine-cytokine receptor interaction, NF-kappa B signaling pathway, Osteoclast differentiation, Parathyroid hormone synthesis, secretion and action, Prolactin signaling pathway, Rheumatoid arthritis 💬[1] 46
6Prolia[1] Denosumab (Synonym: Prolia)[1] D03684 (Name: Prolia (TN))[1] TNFSF11 💬[8] Breast cancer, Chemical carcinogenesis - receptor activation, Cytokine-cytokine receptor interaction, NF-kappa B signaling pathway, Osteoclast differentiation, Parathyroid hormone synthesis, secretion and action, Prolactin signaling pathway, Rheumatoid arthritis 💬[1] 274